Global Glanzmann Thrombasthenia Therapeutic Drug Market Size, Status and Forecast 2024-2031

Report ID: 920056 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Platelet Transfusion
        1.2.3 Recombinant Activated Factor VII
        1.2.4 Antifibrinolytics
        1.2.5 Fibrin Sealants
        1.2.6 Thrombin
        1.2.7 Desmopressin
    1.3 Market by Application
        1.3.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Perspective (2016-2027)
    2.2 Glanzmann Thrombasthenia Therapeutic Drug Growth Trends by Regions
        2.2.1 Glanzmann Thrombasthenia Therapeutic Drug Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Glanzmann Thrombasthenia Therapeutic Drug Historic Market Share by Regions (2016-2021)
        2.2.3 Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Regions (2022-2027)
    2.3 Glanzmann Thrombasthenia Therapeutic Drug Industry Dynamic
        2.3.1 Glanzmann Thrombasthenia Therapeutic Drug Market Trends
        2.3.2 Glanzmann Thrombasthenia Therapeutic Drug Market Drivers
        2.3.3 Glanzmann Thrombasthenia Therapeutic Drug Market Challenges
        2.3.4 Glanzmann Thrombasthenia Therapeutic Drug Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue
        3.1.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue (2016-2021)
        3.1.2 Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Players (2016-2021)
    3.2 Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Glanzmann Thrombasthenia Therapeutic Drug Revenue
    3.4 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio
        3.4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2020
    3.5 Glanzmann Thrombasthenia Therapeutic Drug Key Players Head office and Area Served
    3.6 Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service
    3.7 Date of Enter into Glanzmann Thrombasthenia Therapeutic Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Type
    4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Type (2016-2021)
    4.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Type (2022-2027)

5 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Application
    5.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Application (2016-2021)
    5.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
    6.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
        6.2.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
        6.2.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
        6.2.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
    6.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
        6.3.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
        6.3.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
        6.3.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
    6.4 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
        6.4.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
        6.4.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
    7.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
        7.2.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
        7.2.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
        7.2.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
    7.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
        7.3.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
        7.3.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
        7.3.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
    7.4 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
        7.4.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
        7.4.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
    8.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
        8.2.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
    8.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
        8.3.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
    8.4 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region
        8.4.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
    9.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
        9.2.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
        9.2.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
        9.2.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
    9.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
        9.3.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
        9.3.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
        9.3.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
    9.4 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
        9.4.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
        9.4.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
    10.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
        10.2.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
    10.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
        10.3.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
    10.4 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
        10.4.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Novo Nordisk
        11.1.1 Novo Nordisk Company Details
        11.1.2 Novo Nordisk Business Overview
        11.1.3 Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Introduction
        11.1.4 Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
        11.1.5 Novo Nordisk Recent Development
    11.2 Alnylam Pharmaceuticals
        11.2.1 Alnylam Pharmaceuticals Company Details
        11.2.2 Alnylam Pharmaceuticals Business Overview
        11.2.3 Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Introduction
        11.2.4 Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
        11.2.5 Alnylam Pharmaceuticals Recent Development
    11.3 Shire (Takeda)
        11.3.1 Shire (Takeda) Company Details
        11.3.2 Shire (Takeda) Business Overview
        11.3.3 Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Introduction
        11.3.4 Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
        11.3.5 Shire (Takeda) Recent Development
    11.4 Biogen
        11.4.1 Biogen Company Details
        11.4.2 Biogen Business Overview
        11.4.3 Biogen Glanzmann Thrombasthenia Therapeutic Drug Introduction
        11.4.4 Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
        11.4.5 Biogen Recent Development
    11.5 Bioverativ (Sanofi)
        11.5.1 Bioverativ (Sanofi) Company Details
        11.5.2 Bioverativ (Sanofi) Business Overview
        11.5.3 Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Introduction
        11.5.4 Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
        11.5.5 Bioverativ (Sanofi) Recent Development
    11.6 Bayer
        11.6.1 Bayer Company Details
        11.6.2 Bayer Business Overview
        11.6.3 Bayer Glanzmann Thrombasthenia Therapeutic Drug Introduction
        11.6.4 Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
        11.6.5 Bayer Recent Development
    11.7 CSL Behring
        11.7.1 CSL Behring Company Details
        11.7.2 CSL Behring Business Overview
        11.7.3 CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Introduction
        11.7.4 CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
        11.7.5 CSL Behring Recent Development
    11.8 Grifols
        11.8.1 Grifols Company Details
        11.8.2 Grifols Business Overview
        11.8.3 Grifols Glanzmann Thrombasthenia Therapeutic Drug Introduction
        11.8.4 Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
        11.8.5 Grifols Recent Development
    11.9 Bristol-Myers Squibb
        11.9.1 Bristol-Myers Squibb Company Details
        11.9.2 Bristol-Myers Squibb Business Overview
        11.9.3 Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Introduction
        11.9.4 Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
        11.9.5 Bristol-Myers Squibb Recent Development
    11.10 Pfizer
        11.10.1 Pfizer Company Details
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Glanzmann Thrombasthenia Therapeutic Drug Introduction
        11.10.4 Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
        11.10.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Platelet Transfusion
    Table 3. Key Players of Recombinant Activated Factor VII
    Table 4. Key Players of Antifibrinolytics
    Table 5. Key Players of Fibrin Sealants
    Table 6. Key Players of Thrombin
    Table 7. Key Players of Desmopressin
    Table 8. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions (2016-2021)
    Table 12. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions (2022-2027)
    Table 14. Glanzmann Thrombasthenia Therapeutic Drug Market Trends
    Table 15. Glanzmann Thrombasthenia Therapeutic Drug Market Drivers
    Table 16. Glanzmann Thrombasthenia Therapeutic Drug Market Challenges
    Table 17. Glanzmann Thrombasthenia Therapeutic Drug Market Restraints
    Table 18. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Players (2016-2021)
    Table 20. Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2020)
    Table 21. Ranking of Global Top Glanzmann Thrombasthenia Therapeutic Drug Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Glanzmann Thrombasthenia Therapeutic Drug Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service
    Table 25. Date of Enter into Glanzmann Thrombasthenia Therapeutic Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2016-2021)
    Table 29. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Application (2016-2021)
    Table 33. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Novo Nordisk Company Details
    Table 66. Novo Nordisk Business Overview
    Table 67. Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Product
    Table 68. Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
    Table 69. Novo Nordisk Recent Development
    Table 70. Alnylam Pharmaceuticals Company Details
    Table 71. Alnylam Pharmaceuticals Business Overview
    Table 72. Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Product
    Table 73. Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
    Table 74. Alnylam Pharmaceuticals Recent Development
    Table 75. Shire (Takeda) Company Details
    Table 76. Shire (Takeda) Business Overview
    Table 77. Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Product
    Table 78. Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
    Table 79. Shire (Takeda) Recent Development
    Table 80. Biogen Company Details
    Table 81. Biogen Business Overview
    Table 82. Biogen Glanzmann Thrombasthenia Therapeutic Drug Product
    Table 83. Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
    Table 84. Biogen Recent Development
    Table 85. Bioverativ (Sanofi) Company Details
    Table 86. Bioverativ (Sanofi) Business Overview
    Table 87. Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Product
    Table 88. Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
    Table 89. Bioverativ (Sanofi) Recent Development
    Table 90. Bayer Company Details
    Table 91. Bayer Business Overview
    Table 92. Bayer Glanzmann Thrombasthenia Therapeutic Drug Product
    Table 93. Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
    Table 94. Bayer Recent Development
    Table 95. CSL Behring Company Details
    Table 96. CSL Behring Business Overview
    Table 97. CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Product
    Table 98. CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
    Table 99. CSL Behring Recent Development
    Table 100. Grifols Company Details
    Table 101. Grifols Business Overview
    Table 102. Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
    Table 103. Grifols Recent Development
    Table 104. Bristol-Myers Squibb Company Details
    Table 105. Bristol-Myers Squibb Business Overview
    Table 106. Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Product
    Table 107. Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
    Table 108. Bristol-Myers Squibb Recent Development
    Table 109. Pfizer Company Details
    Table 110. Pfizer Business Overview
    Table 111. Pfizer Glanzmann Thrombasthenia Therapeutic Drug Product
    Table 112. Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
    Table 113. Pfizer Recent Development
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type: 2020 VS 2027
    Figure 2. Platelet Transfusion Features
    Figure 3. Recombinant Activated Factor VII Features
    Figure 4. Antifibrinolytics Features
    Figure 5. Fibrin Sealants Features
    Figure 6. Thrombin Features
    Figure 7. Desmopressin Features
    Figure 8. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application: 2020 VS 2027
    Figure 9. Hospital Case Studies
    Figure 10. Clinic Case Studies
    Figure 11. Others Case Studies
    Figure 12. Glanzmann Thrombasthenia Therapeutic Drug Report Years Considered
    Figure 13. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions: 2020 VS 2027
    Figure 16. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions (2022-2027)
    Figure 17. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Players in 2020
    Figure 18. Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2020
    Figure 20. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2016-2021)
    Figure 21. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2022-2027)
    Figure 22. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2016-2027)
    Figure 24. North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2016-2027)
    Figure 25. North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2016-2027)
    Figure 26. United States Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2016-2027)
    Figure 30. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2016-2027)
    Figure 31. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2016-2027)
    Figure 32. Germany Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Share by Region (2016-2027)
    Figure 42. China Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2016-2027)
    Figure 50. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2016-2027)
    Figure 51. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2016-2027)
    Figure 52. Mexico Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2016-2027)
    Figure 58. Turkey Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Novo Nordisk Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
    Figure 62. Alnylam Pharmaceuticals Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
    Figure 63. Shire (Takeda) Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
    Figure 64. Biogen Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
    Figure 65. Bioverativ (Sanofi) Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
    Figure 66. Bayer Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
    Figure 67. CSL Behring Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
    Figure 68. Grifols Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
    Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
    Figure 70. Pfizer Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novo Nordisk
Alnylam Pharmaceuticals
Shire (Takeda)
Biogen
Bioverativ (Sanofi)
Bayer
CSL Behring
Grifols
Bristol-Myers Squibb
Pfizer
Frequently Asked Questions
Glanzmann Thrombasthenia Therapeutic Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Glanzmann Thrombasthenia Therapeutic Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Glanzmann Thrombasthenia Therapeutic Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Zoned Flash

Market Analysis and Insights: Global Zoned Flash Market
The global Zoned Flash mark ... Read More